Compare PERI & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PERI | CLPT |
|---|---|---|
| Founded | 1999 | 1998 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 428.3M | 467.9M |
| IPO Year | 2005 | 2009 |
| Metric | PERI | CLPT |
|---|---|---|
| Price | $8.79 | $11.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $13.00 | ★ $23.50 |
| AVG Volume (30 Days) | 576.0K | ★ 594.6K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,971,000.00 |
| Revenue This Year | $5.75 | $32.54 |
| Revenue Next Year | $10.33 | $15.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 17.78 |
| 52 Week Low | $7.63 | $8.27 |
| 52 Week High | $11.27 | $30.10 |
| Indicator | PERI | CLPT |
|---|---|---|
| Relative Strength Index (RSI) | 42.70 | 37.95 |
| Support Level | $8.51 | $10.54 |
| Resistance Level | $9.70 | $15.29 |
| Average True Range (ATR) | 0.24 | 0.82 |
| MACD | 0.00 | -0.20 |
| Stochastic Oscillator | 39.80 | 11.21 |
Perion Network Ltd is a technology company. It offers online advertising and search solutions to brands, agencies, and publishers through desktop, mobile, and social channels. It connects advertisers to consumers across digital advertising channels, including search advertising, social, display, video, digital audio, digital out of home (DOOH), and Connected TV (CTV) advertising. The company earns prime revenue from search advertising and display advertising services. It operates in the business segment of High Impact Advertising solutions. Geographically, the company generates a majority of its revenue from the United States and the rest from other regions.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.